BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2107599)

  • 1. Receptor-mediated endocytosis of tissue-type plasminogen activator (t-PA) by liver cells.
    Rijken DC; Otter M; Kuiper J; van Berkel TJ
    Thromb Res Suppl; 1990; 10():63-71. PubMed ID: 2107599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the interaction both in vitro and in vivo of tissue-type plasminogen activator (t-PA) with rat liver cells. Effects of monoclonal antibodies to t-PA.
    Otter M; Kuiper J; Bos R; Rijken DC; van Berkel TJ
    Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):545-50. PubMed ID: 1318035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two receptor systems are involved in the plasma clearance of tissue-type plasminogen activator (t-PA) in vivo.
    Narita M; Bu G; Herz J; Schwartz AL
    J Clin Invest; 1995 Aug; 96(2):1164-8. PubMed ID: 7635954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for carbohydrate-independent endocytosis of tissue-type plasminogen activator by liver cells.
    Stang E; Roos N; Schlüter M; Berg T; Krause J
    Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):799-804. PubMed ID: 1323274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cluster mannosides can inhibit mannose receptor-mediated tissue-type plasminogen activator degradation by both rat and human cells.
    Noorman F; Barrett-Bergshoeff MM; Biessen EA; van de Bilt E; van Berkel TJ; Rijken DC
    Hepatology; 1997 Nov; 26(5):1303-10. PubMed ID: 9362376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
    Sitter T; Toet K; Quax P; Kooistra T
    Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance of tissue plasminogen activator by mannose and galactose receptors in the liver.
    Smedsrød B; Einarsson M
    Thromb Haemost; 1990 Feb; 63(1):60-6. PubMed ID: 2160132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of tissue-type plasminogen activator by human monocyte-derived macrophages is mediated by the mannose receptor and by the low-density lipoprotein receptor-related protein.
    Noorman F; Braat EA; Rijken DC
    Blood; 1995 Nov; 86(9):3421-7. PubMed ID: 7579446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue plasminogen activator is endocytosed by mannose and galactose receptors of rat liver cells.
    Smedsrød B; Einarsson M; Pertoft H
    Thromb Haemost; 1988 Jun; 59(3):480-4. PubMed ID: 2847350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of the mannose receptor from human liver potentially involved in the plasma clearance of tissue-type plasminogen activator.
    Otter M; Zocková P; Kuiper J; van Berkel TJ; Barrett-Bergshoeff MM; Rijken DC
    Hepatology; 1992 Jul; 16(1):54-9. PubMed ID: 1618483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of carbohydrate and protein in the binding of tissue-type plasminogen activator to the human mannose receptor.
    Noorman F; Barrett-Bergshoeff MM; Rijken DC
    Eur J Biochem; 1998 Jan; 251(1-2):107-13. PubMed ID: 9492274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocytosis of the recombinant tissue plasminogen activator alteplase by hepatic endothelial cells.
    Seydel W; Stang E; Roos N; Krause J
    Arzneimittelforschung; 1991 Feb; 41(2):182-6. PubMed ID: 1904231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of tissue-type plasminogen activator by the mannose receptor.
    Otter M; Barrett-Bergshoeff MM; Rijken DC
    J Biol Chem; 1991 Jul; 266(21):13931-5. PubMed ID: 1906888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased clearance explains lower plasma levels of tissue-type plasminogen activator by estradiol: evidence for potently enhanced mannose receptor expression in mice.
    Lansink M; Jong M; Bijsterbosch M; Bekkers M; Toet K; Havekes L; Emeis J; Kooistra T
    Blood; 1999 Aug; 94(4):1330-6. PubMed ID: 10438721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clearance receptors for tissue-type plasminogen activator.
    Camani C; Kruithof EK
    Int J Hematol; 1994 Aug; 60(2):97-109. PubMed ID: 7948967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of mannose receptor-mediated clearance of tissue-type plasminogen activator (t-PA) by dextran: a new explanation for its antithrombotic effect.
    Noorman F; Barrett-Bergshoeff MM; Bekkers M; Emeis JJ; Rijken DC
    Thromb Haemost; 1997 Oct; 78(4):1249-54. PubMed ID: 9364993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonists of the mannose receptor and the LDL receptor-related protein dramatically delay the clearance of tissue plasminogen activator.
    Biessen EA; van Teijlingen M; Vietsch H; Barrett-Bergshoeff MM; Bijsterbosch MK; Rijken DC; van Berkel TJ; Kuiper J
    Circulation; 1997 Jan; 95(1):46-52. PubMed ID: 8994415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine 67 in the epidermal growth factor-like domain of tissue-type plasminogen activator is important for clearance by a specific hepatic receptor.
    Bassel-Duby R; Jiang NY; Bittick T; Madison E; McGookey D; Orth K; Shohet R; Sambrook J; Gething MJ
    J Biol Chem; 1992 May; 267(14):9668-77. PubMed ID: 1315765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-mediated endocytosis of ovalbumin by two carbohydrate-specific receptors in rat liver cells. The intracellular transport of ovalbumin to lysosomes is faster in liver endothelial cells than in parenchymal cells.
    Kindberg GM; Magnusson S; Berg T; Smedsrød B
    Biochem J; 1990 Aug; 270(1):197-203. PubMed ID: 2396980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor-mediated endocytosis of tissue-type plasminogen activator by the human hepatoma cell line Hep G2.
    Owensby DA; Sobel BE; Schwartz AL
    J Biol Chem; 1988 Aug; 263(22):10587-94. PubMed ID: 2839497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.